<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02812784</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0022</org_study_id>
    <nct_id>NCT02812784</nct_id>
  </id_info>
  <brief_title>Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?</brief_title>
  <acronym>AKI-CHECK</acronym>
  <official_title>Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <brief_summary>
    <textblock>
      Patients with septic shock in the intensive care unit have an elevated risk of developing
      acute kidney injury (AKI). AKI is an independent factor for mortality. Interventions that
      limit the worsening of renal function might have an impact on the mortality rate in these
      patients. Given the absence of validated pharmacological treatments for limiting the
      progression of AKI or for accelerating recovery from AKI, early intervention and the
      restoration of the glomerular filtration rate (GFR) in this context of hemodynamic change
      during the initial phase of septic shock might improve the patients' prognosis. One major
      challenge is therefore how to determine whether or not the AKI is reversible. The
      best-studied biomarkers (NGAL and KIM 1) have little discriminant power in septic patients
      because of their poor specificity or unsuitable kinetics for very early diagnosis. The
      combination of urine assays for tissue inhibitor of metalloproteinase 2 (TIMP2) and
      insulin-like growth factor binding protein 7 (IGFBP7) has shown good diagnostic performance
      for the very early detection of the risk of developing AKI in the following 12 hrs. Urine
      levels of these two markers specifically reflect damage to kidney tubules. Moreover, the
      levels appear to be strongly correlated with the severity of tubule damage. Thus, one can
      reasonably hypothesize that measurement of these markers in the very early stages of septic
      shock might determine the presence and severity of kidney tubule damage. A threshold (yet to
      be defined) would help to differentiate between (i) transient, non-severe injury and (ii)
      injury that is already too severe to be reversible.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>KDIGO classification</measure>
    <time_frame>72 hours</time_frame>
    <description>predictive value of Nephrocheck™ with regard to the reversibility of AKI, defined as the recovery of normal renal function (KDIGO 0) in the 72 hours following inclusion</description>
  </primary_outcome>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Heading</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nephrocheck TM</intervention_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Septic shock (according to Bone's criteria) within 4 hours of introduction of
        catecholamines
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or over

          -  Septic shock (according to Bone's criteria) within 4 hours of introduction of
             catecholamines

          -  AKI, characterized by a KDIGO score ≥ 1

          -  Social security coverage

        Exclusion Criteria:

          -  AKI requiring emergency RRT (in the critical care physician's opinion).

          -  Anuria

          -  Stage 4-5 chronic kidney failure with a GFR below 30 ml/min.

          -  Rapidly progressing renal disorders (glomerulonephritis, HUS, blockage, etc.)

          -  Obstructive AKI

          -  Probable glomerular damage (nephritic syndrome, nephrotic syndrome, chronic
             glomerulonephritis)

          -  Pregnancy or breastfeeding

          -  Legal guardianship or lack of social security coverage.

          -  Cardiocirculatory arrest

          -  Life expectancy &lt;48 hours.

          -  Child C cirrhosis

          -  Prior occurrence of AKI during the current hospital stay

          -  Transplantation

          -  Subject participating in another study with an exclusion period ongoing at the time of
             the pre-inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien MAIZEL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien MAIZEL, Md, PhD</last_name>
    <phone>+33 3 22 08 78 07</phone>
    <email>maizel.julien@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julien MAIZEL, MD, PhD</last_name>
      <phone>+33 3 22 08 78 07</phone>
      <email>maizel.julien@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Avranches-Granville</name>
      <address>
        <city>Avranches</city>
        <zip>50300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric GODDE, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Cahors</name>
      <address>
        <city>Cahors</city>
        <zip>46000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karim CHAOUKI, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Dax</name>
      <address>
        <city>Dax</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maude ANDRIEU, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Marc Jacquet</name>
      <address>
        <city>Melun</city>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe VINSONNEAU</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Princesse de Grace</name>
      <address>
        <city>Monaco</city>
        <zip>98000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabelle ROUQUETTE-VINCENTI, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Mont-de-Marsan</name>
      <address>
        <city>Mont-de-Marsan</city>
        <zip>40000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel PASCAL</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34172</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kada KLOUCHE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Paris-Saint Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoît MISSET</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>René ROBERT, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe MARIAT, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Salon-de-provence</name>
      <address>
        <city>Salon-de-provence</city>
        <zip>13300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hicham BAHLOUL, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nephrocheck™</keyword>
  <keyword>acute kidney injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

